Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Downing

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 6, 2012
The lymphocyte crossmatch by flow cytometry for kidney transplantationJonathan Downing
Immunogenetics|January 20, 2022
High-resolution human KIR genotypingJonathan Downing, Lloyd D'Orsogna
Transplantation|April 21, 2025
HLA-EP-RESOLVER: A Novel Web-based Bioinformatic Tool to Determine the Presence or Absence of DSA Against Rare HLA Alleles in the Era of Rapid High-resolution Deceased Donor HLA GenotypingLinh Truong, Fredrick Mobegi, Babette Vogels, et al.
Biochemical Society Transactions|September 16, 2022
Protective HLA-B57: T cell and natural killer cell recognition in HIV infectionChristian A Lobos, Jonathan Downing, Lloyd J D'Orsogna, et al.
HLA|April 14, 2020
Different eplet software programs give discordant and incorrect results: An analysis of HLAMatchmaker vs Fusion Matchmaker Eplet calling softwareGabriella Tassone, Dianne De Santis, Irena Vukovic, et al.
HLA|September 23, 2025
Allele Level Sequencing of Killer Cell Immunoglobulin-Like Receptor Genes Using Oxford Nanopore Long Read SequencingJonathan Downing, Daniel Abromeit, Linh Truong, et al.
HLA|February 28, 2023
C3d-binding assay for the detection of complement activating HLA antibodies: A useful tool for allocation to highly sensitised recipients in the post-CDC era?Zo Ee Wong, Jonathan Downing, Dianne De Santis, et al.
Human Immunology|December 1, 2022
Do variations in the HLA-E ligand encoded by UL40 distinguish individuals susceptible to HCMV disease?Shelley Waters, Richard J N Allcock, Silvia Lee, et al.
Internal Medicine Journal|February 23, 2023
A novel allocation strategy for the difficult-to-allocate donor: audit of deceased donor kidneys utilised for preemptive recipients within Western AustraliaRishabh Kulkarni, Zo E Wong, Jonathan Downing, et al.
International Journal of Molecular Sciences|November 13, 2020
Platelet-Reactive Antibodies in Patients after Ischaemic Stroke-An Epiphenomenon or a Natural Protective MechanismYoung Eun Park, Rushi Penumarthy, Paul P Sun, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|June 6, 2012
The lymphocyte crossmatch by flow cytometry for kidney transplantationJonathan Downing
Immunogenetics|January 20, 2022
High-resolution human KIR genotypingJonathan Downing, Lloyd D'Orsogna
Transplantation|April 21, 2025
HLA-EP-RESOLVER: A Novel Web-based Bioinformatic Tool to Determine the Presence or Absence of DSA Against Rare HLA Alleles in the Era of Rapid High-resolution Deceased Donor HLA GenotypingLinh Truong, Fredrick Mobegi, Babette Vogels, et al.
Biochemical Society Transactions|September 16, 2022
Protective HLA-B57: T cell and natural killer cell recognition in HIV infectionChristian A Lobos, Jonathan Downing, Lloyd J D'Orsogna, et al.
HLA|April 14, 2020
Different eplet software programs give discordant and incorrect results: An analysis of HLAMatchmaker vs Fusion Matchmaker Eplet calling softwareGabriella Tassone, Dianne De Santis, Irena Vukovic, et al.
HLA|September 23, 2025
Allele Level Sequencing of Killer Cell Immunoglobulin-Like Receptor Genes Using Oxford Nanopore Long Read SequencingJonathan Downing, Daniel Abromeit, Linh Truong, et al.
HLA|February 28, 2023
C3d-binding assay for the detection of complement activating HLA antibodies: A useful tool for allocation to highly sensitised recipients in the post-CDC era?Zo Ee Wong, Jonathan Downing, Dianne De Santis, et al.
Human Immunology|December 1, 2022
Do variations in the HLA-E ligand encoded by UL40 distinguish individuals susceptible to HCMV disease?Shelley Waters, Richard J N Allcock, Silvia Lee, et al.
Internal Medicine Journal|February 23, 2023
A novel allocation strategy for the difficult-to-allocate donor: audit of deceased donor kidneys utilised for preemptive recipients within Western AustraliaRishabh Kulkarni, Zo E Wong, Jonathan Downing, et al.
International Journal of Molecular Sciences|November 13, 2020
Platelet-Reactive Antibodies in Patients after Ischaemic Stroke-An Epiphenomenon or a Natural Protective MechanismYoung Eun Park, Rushi Penumarthy, Paul P Sun, et al.
Pageof 2